COVID-19
US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal
October 28, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma
The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …
US could have avoided over 130,000 COVID-19 deaths, according to a new study
October 27, 2020Manufacturing and Production COVID, COVID-19, Trump, coronavirus
New studies suggest that the US could have avoided over 130,000 deaths if it responded earlier and in a coordinated …
AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants
October 26, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine
AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …
WHO warns regulators to consider all available evidence before approving remdesivir for COVID-19
October 26, 2020Sales and Marketing COVID, COVID-19, Gilead, coronavirus
The World Health Organization’s Chief Scientist Soumya Swaminathan has warned that experts and regulators assessing the use of Gilead’s remdesivir …
FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients
October 23, 2020Medical Communications, Sales and Marketing COVID-19, FDA, Gilead, remdesivir
The FDA has approved Gilead’s antiviral therapy Veklury (remdesivir) for the treatment of hospitalised COVID-19 patients, making it the first …
Spain secures 31.6 million doses of AstraZeneca’s COVID-19 vaccine
October 21, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Spain, Vaccine
AstraZeneca continues to forge agreements with national governments to deliver its vaccine against COVID-19, with Spain becoming the latest country …
Eli Lilly refutes FDA quality concerns at New Jersey facility producing COVID-19 drug
October 21, 2020Manufacturing and Production, Research and Development COVID-19, Eli Lilly, FDA, pharma
Eli Lilly has rebutted reports of FDA quality assurance concerns at its manufacturing facility in Branchburg, New Jersey, where it …
Pharmafile.com’s weekly COVID-19 news round-up
October 21, 2020Research and Development COVID-19, coronavirus
The coronavirus news this week focuses on COVID-19 treatments, with Gilead’s remdesivir being found to have no impact on mortality …
European Commission stands by €1bn remdesivir supply deal despite disappointing COVID-19 benefit
October 19, 2020Manufacturing and Production, Sales and Marketing COVID-19, Europe, Gilead, remdesivir
As Europe continues to face down a rising second wave of COVID-19, the European Commission quickly moved to secure a …
Pfizer won’t apply for COVID-19 vaccine emergency authorisation until after US election, CEO says
October 19, 2020Sales and Marketing COVID-19, Pfizer, US, Vaccine
The Chief Executive Officer of Pfizer has said that the company will now submit their vaccine for FDA Emergency Use …
Gilead’s remdesivir and three other repurposed drugs have no impact on COVID-19 mortality, WHO study finds
October 16, 2020Medical Communications, Research and Development COVID-19, pharma, remdesivir
Gilead’s antiviral therapy remdesivir has emerged as one of the most promising drugs to treat COVID-19 infections, but recent studies …
80 researchers argue COVID-19 herd immunity strategy is a “dangerous fallacy” in open letter
October 15, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19
A group of 80 researchers have lent their signatures to an open letter published in the The Lancet under the …
British man suffers from permanent hearing damage after contracting COVID-19
October 14, 2020Research and Development COVID-19, pharma
A 45-year-old man in the UK has been left with permanent hearing damage after being infected with the novel coronavirus, …
Pharmafile.com’s weekly COVID-19 news round-up
October 14, 2020Research and Development COVID-19, coronavirus, covid news, pandemic, weekly roundup
The COVID-19 news this week focuses on FDA authorisations, with Eli Lilly seeking Emergency Use Authorization (EUA) from the FDA …
J&J halts COVID-19 vaccine study following unidentified participant illness
October 13, 2020Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma
Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
